
==== Front
Case Rep Otolaryngol
Case Rep Otolaryngol
CRIOT
Case Reports in Otolaryngology
2090-6765
2090-6773
Wiley

10.1155/2024/6335543
Case Report
Lemierre Syndrome with Extensive Thrombosis: A Unique Case Report and Literature Review
https://orcid.org/0009-0001-6443-548X
Koukias Stergos stergoskoykias@gmail.com
1
https://orcid.org/0009-0000-6662-8544
Athousaki Asimenia 1
https://orcid.org/0000-0003-3448-1191
Klonaris Dionisios 2
https://orcid.org/0000-0002-8087-1011
Kavousanaki Melina 1
https://orcid.org/0009-0004-0710-933X
Papazoglou Georgios 1
https://orcid.org/0009-0004-7292-3354
Papanikolaou Nikolaos 1
1 1st Department of Internal Medicine General Hospital of Heraklion “Venizeleio-Pananeio”, Heraklion, Crete, Greece
2 Department of Otorhinolaryngology-Head and Neck Surgery General Hospital of Heraklion “Venizeleio-Pananeio”, Heraklion, Crete, Greece
Academic Editor: Dinesh K. Chhetri

2024
3 9 2024
2024 633554310 1 2024
12 8 2024
28 8 2024
Copyright © 2024 Stergos Koukias et al.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background

Lemierre syndrome (LS) is a rare complication of upper aerodigestive tract infections characterized by proximal and distal septic emboli, commonly including internal jugular vein (IJV) thrombosis. Diagnosis can be challenging, and treatment delays can result in increased patient morbidity and mortality. We present a rare case of LS with extensive thrombosis and multiple sites of distal infection and a narrative review of the literature. Case Presentation. A 52-year-old Caucasian male was transferred to the emergency department (ED) with an altered level of consciousness and clinical findings of acute bacterial pharyngotonsillitis. Medical history included cervical spine disorder and traumatic brain injury in the past, as well as the recent use of pain relievers due to acute cervical pain. Imaging studies revealed left IJV thrombosis that extended into multiple venous cerebral sinuses and infiltrates of the right lung. LS was considered the most likely diagnosis. The patient was intubated and transferred to the intensive care unit (ICU). Treatment included intravenous broad-spectrum antibiotics and anticoagulation therapy. Response to treatment was satisfactory. After extubation, he was transferred to a ward and discharged with resolution of clinical and imaging findings.

Conclusion

LS is a rare disease and may have an insidious course. Timely diagnosis and appropriate treatment strategies, mainly broad-spectrum antibiotics, offer favorable outcomes in otherwise healthy individuals. The indications for anticoagulation therapy still remain controversial. Anticoagulants are usually administered to patients with extensive thrombosis. Surgical treatment includes abscess drainage, while IJV ligation and excision are reserved for nonresponders to medical treatment.
==== Body
pmc1. Introduction

Lemierre syndrome (LS) is a rare disease first described in 1936 by Andre Lemierre and typically refers to an oropharyngeal bacterial infection complicated by septic thrombophlebitis of the internal jugular vein (IJV) [1]. It occurs mainly in young male adults [2, 3]. The obligate Gram-negative anaerobic bacterium Fusobacterium necrophorum (FN), part of the oropharyngeal flora, constitutes the most common causative organism of this syndrome. However, in many cases, several species of Streptococcus also participate in the pathogenesis. Given the inherent resistance of FN to macrolides, quinolones, tetracyclines, and aminoglycosides and its ability to produce beta-lactamases, empirical antibiotic therapy should include combination therapy that targets FNs producing beta-lactamase and oral and pharyngeal streptococci [4–7]. Appropriate antimicrobial therapy is vital for a favorable disease outcome, considering the high mortality rate in the pre-antibiotic era and the subsequent significantly lower 5% rate in the last two decades [8, 9]. We present a rare case of LS with extensive thrombosis and multiple distal infection sites.

2. Case Presentation

A 52-year-old male, with a medical history of cervical spine disorder and traumatic brain injury in the past, was transferred to the emergency department (ED) due to altered level of consciousness and dizziness. His relatives reported that during the last month, the patient suffered from severe intractable cervical pain and was treated with nonsteroidal anti-inflammatory drugs, tramadol, and physical therapy. The Glasgow Coma Scale was 8/15, so the patient was intubated. Empirical prompt antibiotic therapy with ceftriaxone and vancomycin was initiated due to high clinical suspicion of central nervous system (CNS) infection. Brain computerized tomography (CT) revealed extensive thrombosis of multiple venous cerebral sinuses (transverse, sigmoid, and cavernous sinuses bilaterally and superior sagittal sinus), as well as IJVs and retinal veins bilaterally (Figure 1). The findings of chest CT were ground-glass opacities of the right lung (Figure 2). The laboratory test results revealed marked leukocytosis and increased levels of C-reactive protein. A lumbar puncture was performed. Cerebrospinal fluid (CSF) analysis showed a total leukocyte count of 438 per liter and a differential neutrophil count of 85%. The CSF and blood cultures were sterile. Further physical examination revealed edema and fluid collection in the left temporomandibular joint and the left parotid gland. Paracentesis and aspiration of both fluid collections were performed. The fluid leukocyte count and differential were unremarkable, while the fluid culture was sterile.

The patient was intubated in the ED and transferred to the intensive care unit (ICU), where he remained for 10 days. He was treated with intravenous ceftazidime/avibactam, vancomycin, ampicillin, and metronidazole. He was also treated with enoxaparin for thrombosis. Post-extubation, the patient was transferred from the ICU to a general ward in the Department of Internal Medicine.

A new brain and neck CT revealed fluid collection in both the middle ear and mastoid cavities (Figure 3), as well as persistence of the IJV thrombi, asymmetry of the left pharyngeal wall, and inflammatory changes in the left carotid and post-styloid parapharyngeal spaces (Figure 4).

ENT head and neck examination revealed an asymmetry of the left lateral pharyngeal wall, indicative of inflammation of the ipsilateral pharyngeal band and deep neck spaces. Otomicroscopy revealed bilateral serous otitis media. Myringotomy was performed on both sides and serous otomastoiditis was diagnosed. However, this diagnosis would not explain intracranial complications on admission, since it was not present at the time. No significant enlarged lymph nodes or masses were found on head and neck examination. On flexible fiberoptic endoscopy, seropurulent secretions were identified in the nasal cavity, and uncomplicated acute bacterial rhinosinusitis was diagnosed. The asymmetry in the left lateral pharyngeal wall was confirmed, with a normal appearance of the supraglottic larynx.

Taking into account the medical history, the findings of the physical examination, and the medical imaging, LS was considered the most probable diagnosis. Empirical antibiotic treatment was modified to intravenous meropenem, linezolid, and metronidazole against common LS and other deep neck space and CNS infection bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), and FS. Anticoagulation therapy was also modified to per os acenocoumarol.

Intravenous antibiotic treatment continued for three weeks. During this time, the patient became afebrile and hemodynamically stable. The laboratory test results returned to normal levels, and the blood cultures were sterile. He was discharged from the hospital on per os linezolid and metronidazole for six weeks, as well as per os acenocoumarol for six months. On discharge, contrast-enhanced head and neck CT revealed no change in the left transverse and sigmoid sinuses, while a significant reduction of thrombus extension was observed in the rest of the venous sinuses. The patient was scheduled for monthly outpatient medical visits. After six months, he completely recovered with no neurological deficits or abnormal findings on physical examination.

3. Discussion

According to the bibliography, LS is a rare disorder [7]. However, since the 1980s, there has been an upward trend in the number of reported cases [10]. The appearance of resistant microorganism strains due to overprescription of antibiotics for pharyngotonsillitis could be an explanation for this observation [11]. A large prospective study in Denmark reported that the overall incidence of LS is up to 3.6 cases per million and considerably higher (14.4 cases per million) in the age subgroup of young adults (14–25 years) [2]. The reason why young adults are more vulnerable to LS remains unclear. It has been suggested that the conversion from aerobic to anaerobic oral and pharyngeal flora in late childhood and puberty could be a possible explanation [12].

The most common primary site of infection in LS is the palatine tonsils, through which pathogens can invade the deep neck spaces. Subsequently, septic thrombophlebitis of the IJV, septic emboli, and infection of other distal sites can occur. In one published case report, pharyngitis was considered the primary site of infection with subsequent extension to the left parapharyngeal space, followed by metastatic infection of the lungs and the CNS. The most common site of metastatic infection in LS is the lungs, while the CNS is rarely implicated [13].

The release of proinflammatory cytokines at the site of infection could be the main culprit causing endothelial injury and venous thrombosis, typical features of LS [14]. Infection spreading through tissue, hematogenous, or lymphatic routes is considered the main mechanism of disease pathogenesis [7]. In our case report, the patient suffered from extension of infection into the IJVs, multiple venous cerebral sinuses, and the retinal veins.

A recent meta-analysis confirmed that the most common site of thrombosis and septic thrombophlebitis is the IJV and reported a wide spectrum of sites of thrombosis in LS, including the cerebral venous sinuses and the retinal veins [5]. The author also reported the results of the blood and tissue cultures of the patients. In 7.9% of the cases, the cultures were sterile and the responsible microorganism was not identified [5]. The main responsible organism is FN, which constitutes part of the normal oral and pharyngeal flora [5, 12]. Several other species of the same genus (e.g., Fusobacterium nucleatum), Streptococcus spp., Peptostreptococcus spp., Staphylococcus spp. (including MRSA), and Bacteroides spp. have been described as possible pathogens [5, 6, 10]. In our case report, no responsible microorganisms were identified. This can be explained by the inherently demanding and difficult cultivation of FN and anaerobes in general [15].

The administration of broad-spectrum antibiotics is the mainstay of empiric therapy for LS, pending the culture and susceptibility results. Antibiotic regimens should target FN and oral streptococci. The constitutive resistance of FN in macrolides, fluoroquinolones, tetracyclines, and aminoglycosides and beta-lactamase production by FN have been shown in many previous studies [6, 11, 13, 16, 17]. Antibiotics such as beta-lactams combined with a beta-lactamase inhibitor, metronidazole, clindamycin, and carbapenems appear to be efficient drugs, showing good in vitro susceptibility in isolated species of FN [18, 19]. The duration of therapy should be three to six weeks. Intravenous antibiotics can be switched to oral regimens as soon as infection is controlled [20]. In our case report, the patient was initially treated in the ICU with a variety of antibiotics (ceftazidime/avibactam, vancomycin, ampicillin, and metronidazole) against CNS infection and pneumonia. Although ampicillin administration is not recommended due to the high rates of antimicrobial resistance compared to piperacillin/tazobactam and carbapenems, Listeria spp. CNS infection was also in the differential diagnosis and had to be managed. Patients with proven CNS infection need broad-spectrum antibiotic coverage, penetrating the blood-brain barrier (e.g. vancomycin, third-generation cephalosporins, and metronidazole) [15]. When the diagnosis of LS was established after the patient was transferred from the ICU to a general ward, antibiotic treatment was modified to meropenem, linezolid, and metronidazole targeting MRSA, VRSA, and FN, considering sterile blood cultures.

Anticoagulation therapy for the management of septic embolism in LS remains contentious and is a subject of controversy between clinicians. Several studies showed clinical improvement regardless of anticoagulation therapy administration [21, 22]. Significant improvement was found in a retrospective study published by Rebelo et al. [23]. The impact of anticoagulation on vessel recanalization and mortality was not statistically significant in patients administered anticoagulation in a recent meta-analysis. In the bibliography, anticoagulation therapy has been proposed in high-risk patients when there are no contraindications. The rationale is that it accelerates thrombus lysis and prevents relapses, especially in intracranial thrombosis [24–26]. Low-molecular-weight heparin (LMWH) and warfarin have been widely used for the treatment of thrombosis in LS. In terms of children, exclusive administration of LMWH is recommended [22, 27]. The optimal duration of therapy is not yet clear. In our case report, anticoagulation was considered important due to extensive thrombosis of the left IJV and multiple cerebral venous sinuses. The duration of therapy for six months has been recommended. In patients with multiple sites of thrombosis, the administration of warfarin or acenocoumarol has been proposed with simultaneous INR monitoring, targeting 2.5 [28].

In the pre-antibiotic era, due to the high mortality rates of LS, surgical treatment was considered standard of care, given the paucity of therapeutic means. Ligation and excision of the thrombosed IJV remained the only viable option for the prevention of fatal outcomes [10]. The rationale behind this was to remove the site of sustained proliferation of pathogens inside blood clots and prevent their release to the circulation. Studies have also shown limited penetration of antibiotics into intravascular thrombi, leading to decreased response to treatment [24]. Currently, surgical treatment is aimed to abscess drainage, while surgical excision and ligation of the IJV are reserved in cases with a poor response to antibiotic therapy [27].

4. Conclusion

LS is a rare disease and, if untreated, has high morbidity and mortality rates. Due to its usually insidious course, a timely diagnosis and appropriate treatment strategies are imperative to favorable outcomes. Currently, the administration of broad-spectrum antibiotics is the mainstay of empiric therapy for LS. The indications for anticoagulation therapy still remain a matter of debate between clinicians, and such regimens are usually administered to patients with extensive thrombosis. Surgical treatment of LS includes abscess drainage, while IJV ligation and excision are reserved for nonresponders to medical treatment.

Data Availability

All necessary data supporting the study findings are incorporated in the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Figure 1 Contrast-enhanced brain CT showing thrombosis of multiple venous cerebral sinuses. The paranasal sinuses, as well as the middle ear and mastoid cavities, are free from fluid collection.

Figure 2 Chest CT showing ground-glass opacities and infiltrate of the right lung.

Figure 3 Brain CT showing fluid collection in both the middle ear and the mastoid cavities.

Figure 4 Contrast-enhanced neck CT showing persistence of the IJV thrombi, asymmetry of the left pharyngeal wall, and enlargement of the left carotid and post-styloid parapharyngeal spaces.
==== Refs
1 Holm K. Bank S. Nielsen H. Kristensen L. H. Prag J. Jensen A. The role of fusobacterium necrophorum in pharyngotonsillitis-a review Anaerobe 2016 42 89 97 10.1016/j.anaerobe.2016.09.006 2-s2.0-84988910367 27693542
2 Hagelskjaer Kristensen L. Prag J. Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey European Journal of Clinical Microbiology & Infectious Diseases 2008 27 9 779 789 10.1007/s10096-008-0496-4 2-s2.0-49649089769 18330604
3 Ramirez S. Hild T. G. Rudolph C. N. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a children’s Hospital Pediatrics 2003 112 5 p. e380 10.1542/peds.112.5.e380 2-s2.0-19244372002
4 Seidenfeld S. M. Sutker W. L. Luby J. P. Fusobacterium necrophorum septicemia following oropharyngeal infection JAMA-Journal of the American Medical Association 1982 248 11 1348 1350 10.1001/jama.1982.03330110044024 2-s2.0-0019983052
5 Gore M. R. Lemierre syndrome: a meta-analysis International Archives of Otorhinolaryngology 2020 24 03 e379 e385 10.1055/s-0039-3402433 32754251
6 Golpe R. Marin B. Alonso M. Lemierre’s syndrome (necrobacillosis) Postgraduate Medical Journal 1999 75 881 141 144 10.1136/pgmj.75.881.141 10448489
7 Osowicki J. Kapur S. Phuong L. K. Dobson S. The long shadow of lemierre’s syndrome Journal of Infection 2017 74 Suppl 1 S47 S53 10.1016/s0163-4453(17)30191-3 2-s2.0-85026212356 28646962
8 Karkos P. D. Asrani S. Karkos C. D. Lemierre’s syndrome: a systematic review The Laryngoscope 2009 119 8 1552 1559 10.1002/lary.20542 2-s2.0-68849106328 19554637
9 Valerio L. Zane F. Sacco C. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases Journal of Internal Medicine 2021 289 3 325 339 10.1111/joim.13114 32445216
10 Sinave C. P. Hardy G. J. Fardy P. W. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection Medicine (Baltimore) 1989 68 2 85 94 10.1097/00005792-198903000-00002 2-s2.0-0024603086 2646510
11 Nord C. E. Heimdahl A. Tunér K. Beta-lactamase producing anaerobic bacteria in the oropharynx and their clinical relevance Scandinavian Journal of Infectious Diseases-Supplementum 1988 57 50 54 3074472
12 Jensen A. Kristensen L. H. Prag J. Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR Clinical Microbiology and Infection 2007 13 7 695 701 10.1111/j.1469-0691.2007.01719.x 2-s2.0-34250352750 17403128
13 Kuppalli K. Livorsi D. Talati N. J. Osborn M. Lemierre’s syndrome due to Fusobacterium necrophorum The Lancet Infectious Diseases 2012 12 10 808 815 10.1016/s1473-3099(12)70089-0 2-s2.0-84866619160 22633566
14 Pober J. S. Activation and injury of endothelial cells by cytokines Pathologie Biologie 1998 46 3 159 163 9769910
15 Brook I. Wexler H. M. Goldstein E. J. C. Antianaerobic antimicrobials: spectrum and susceptibility testing Clinical Microbiology Reviews 2013 26 3 526 546 10.1128/cmr.00086-12 2-s2.0-84879763980 23824372
16 Brook I. Infections caused by beta-lactamase-producing Fusobacterium spp. in children The Pediatric Infectious Disease Journal 1993 12 6 532 533 10.1097/00006454-199306000-00014 2-s2.0-0027262192 8345986
17 Freeman C. D. Klutman N. E. Lamp K. C. Metronidazole. A therapeutic review and update Drugs 1997 54 5 679 708 10.2165/00003495-199754050-00003 2-s2.0-0030703162 9360057
18 Brazier J. S. Hall V. Yusuf E. Duerden B. I. Fusobacterium necrophorum infections in england and wales 1990-2000 Journal of Medical Microbiology 2002 51 3 269 272 10.1099/0022-1317-51-3-269 2-s2.0-0036181918 11871622
19 Yusuf E. Halewyck S. Wybo I. Piérard D. Gordts F. Fusobacterium necrophorum and other Fusobacterium spp. isolated from head and neck infections: a 10-year epidemiology study in an academic hospital Anaerobe 2015 34 120 124 10.1016/j.anaerobe.2015.05.006 2-s2.0-84930622068 25988544
20 Walkty A. Embil J. Lemierre’s syndrome New England Journal of Medicine 2019 380 12 p. e16 10.1056/nejmicm1808378 2-s2.0-85063327344
21 Cupit-Link M. C. Nageswara Rao A. Warad D. M. Rodriguez V. Lemierre syndrome: a retrospective study of the role of anticoagulation and thrombosis outcomes Acta Haematologica 2017 137 2 59 65 10.1159/000452855 2-s2.0-85008386296 28006761
22 Phan T. So T. Y. Use of anticoagulation therapy for jugular vein thrombus in pediatric patients with Lemierre’s syndrome International Journal of Clinical Pharmacy 2012 34 6 818 821 10.1007/s11096-012-9684-5 2-s2.0-84872177034 22899236
23 Rebelo J. Nayan S. Choong K. Fulford M. Chan A. Sommer D. D. To anticoagulate? Controversy in the management of thrombotic complications of head and neck infections International Journal of Pediatric Otorhinolaryngology 2016 88 129 135 10.1016/j.ijporl.2016.06.013 2-s2.0-84978038779 27497400
24 Bergeron M. G. Robert J. Beauchamp D. Pharmacodynamics of antibiotics in fibrin clots Journal of Antimicrobial Chemotherapy 1993 31 Suppl D 113 136 10.1093/jac/31.suppl_d.113 2-s2.0-0027243217
25 Lustig L. R. Cusick B. C. Cheung S. W. Lee K. C. Lemierre’s syndrome: two cases of postanginal sepsis Otolaryngology-Head and Neck Surgery 1995 112 6 767 772 10.1016/s0194-5998(95)70192-3 2-s2.0-0029059449 7777368
26 Bondy P. Grant T. Lemierre’s syndrome: what are the roles for anticoagulation and long-term antibiotic therapy? Annals of Otology, Rhinology & Laryngology 2008 117 9 679 683 10.1177/000348940811700909 2-s2.0-54249128683 18834071
27 Johannesen K. M. Bodtger U. Lemierre’s syndrome: current perspectives on diagnosis and management Infection and Drug Resistance 2016 9 221 227 10.2147/idr.s95050 2-s2.0-84989162262 27695351
28 McGouran D. Keene A. Walklin R. Carter J. A complex case of bilateral Lemierre syndrome with suggestions on anticoagulation management Internal Medicine Journal 2013 43 6 728 730 10.1111/imj.12162 2-s2.0-84879020116 23745997
